Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Jul 2, 2009

Premium

Gentel Biosciences commercially launched its APiX Chromogenic Protein Array system this week. The technology was previously available only in-house for Gentel's custom services business.

The system comprises a scanner with optional analysis software, proprietary surface chemistry substrates, and licensed detection reagents. In a statement, Gentel said the APiX Chromogenic offers flexibility and functionality to researchers who print their own arrays as well as those who purchase ready-to-use arrays and kits.

Alex Vodenlic, president and CEO of Gentel, added that the firm will launch "several" new APiX-based applications covering areas such as animal diagnostics, pathway analysis, cancer research, biomarker discovery, screening, and validation.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.